About Us
Breakthrough Immunotherapeutics
against incurable diseases
- Eu New
- ti Terapia Immunologica
- lex Principle or Method
Welcome to the Eutilex
Eutilex is a collection of people who are committed to improve health and well-being around the world. The core technology that the Eutilex employs for drug development is selecting targets that faithfully enhance or suppress human immune responses. A series of immunomodulatory antibody therapeutics have been developed on that principle to treat cancers and autoimmune diseases.
Another core technology of the Eutilex is to employ human peripheral T lymphocytes as a therapeutics. One of the product, 4-1BB CTL, is being tested in clinic against various hematologic and solid cancers.
Both antibodies and T cell therapeutics are expected to produce powerful therapeutic activities with no or minimal toxicity.
We, the Eutilex people, promise to provide better therapeutics to cure the incurable human diseases.
Another core technology of the Eutilex is to employ human peripheral T lymphocytes as a therapeutics. One of the product, 4-1BB CTL, is being tested in clinic against various hematologic and solid cancers.
Both antibodies and T cell therapeutics are expected to produce powerful therapeutic activities with no or minimal toxicity.
We, the Eutilex people, promise to provide better therapeutics to cure the incurable human diseases.